scanX
Home
Makers Laboratories

Makers Laboratories

209.50
-9.60
(-4.38%)
Market Cap (₹ Cr.)
₹129
52 Week High
230.00
Book Value
₹107
52 Week Low
108.40
PE Ratio
24.21
PB Ratio
1.97
PE for Sector
49.51
PB for Sector
19.74
ROE
-4.61 %
ROCE
-1.58 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
2.22 %
Net Income Growth
118.18 %
Cash Flow Change
109.74 %
ROE
130.50 %
ROCE
-253.40 %
EBITDA Margin (Avg.)
-54.22 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
14
18
17
13
15
14
19
14
14
11
18
15
14
15
15
11
9
10
17
11
13
9
14
11
11
15
16
14
9
10
12
11
11
12
16
11
12
12
22
Expenses
13
15
15
12
15
12
17
12
14
11
15
13
13
13
13
11
8
10
16
11
11
8
12
11
10
14
14
12
10
11
12
13
11
13
16
12
12
13
12
EBITDA
1
2
1
1
0
2
2
2
1
0
3
2
2
2
2
0
2
-0
1
0
2
1
2
-0
1
1
2
2
-1
-1
0
-2
0
-2
0
-1
0
-0
10
Operating Profit %
4 %
13 %
7 %
8 %
-2 %
10 %
10 %
10 %
5 %
1 %
13 %
9 %
7 %
8 %
7 %
-5 %
6 %
-1 %
6 %
2 %
12 %
13 %
13 %
-5 %
7 %
8 %
10 %
11 %
-11 %
-16 %
-5 %
-17 %
-2 %
-16 %
-5 %
-10 %
-1 %
-2 %
-1 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
0
Profit Before Tax
0
2
1
1
-0
2
2
1
1
-0
2
1
1
1
1
-0
1
-1
1
-1
1
0
1
-2
-1
0
1
1
-2
-2
-1
-3
-1
-3
-1
-2
-1
-1
9
Tax
0
1
0
0
-0
1
1
0
0
0
1
0
0
0
0
-0
0
0
0
0
0
0
-0
-0
0
0
0
-0
-0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
1
1
1
-0
1
1
1
0
-0
2
1
1
1
1
-0
1
-1
0
-0
0
0
1
-2
-1
0
1
1
-2
-2
-1
-3
-1
-3
-1
-2
-2
-1
8
EPS in ₹
0.61
2.68
1.30
0.98
-0.27
2.57
2.46
2.21
0.29
-0.32
3.65
1.24
1.65
1.95
1.90
-0.47
1.60
-1.26
0.64
-0.32
0.68
0.03
1.92
-3.71
-1.52
0.60
1.65
1.36
-3.26
-3.97
-1.07
-4.25
-1.29
-4.17
-1.68
-3.30
-2.64
-2.07
13.62
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
39
40
50
53
60
74
79
86
85
86
Fixed Assets
12
10
17
17
18
33
31
30
40
40
Current Assets
22
23
25
28
23
24
23
21
19
21
Capital Work in Progress
3
4
0
0
6
1
0
9
0
0
Investments
0
0
7
9
11
15
24
23
23
23
Other Assets
25
26
26
27
24
25
25
24
22
24
Total Liabilities
39
40
50
53
60
74
79
86
85
86
Current Liabilities
10
10
15
16
11
19
21
30
21
26
Non Current Liabilities
5
4
1
1
7
10
8
6
6
9
Total Equity
25
26
34
37
42
45
50
50
58
51
Reserve & Surplus
20
21
29
32
37
40
45
45
52
46
Share Capital
5
5
5
5
5
5
5
5
6
6
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
1
3
-3
1
-1
-1
-0
0
0
Investing Activities
-1
-2
-3
-2
-8
-8
-3
-9
-4
-2
Operating Activities
1
4
6
0
5
4
1
7
-1
-3
Financing Activities
-0
-1
0
-1
4
3
1
2
5
5
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
58.37 %
58.37 %
58.37 %
58.37 %
58.37 %
61.27 %
61.27 %
61.27 %
61.27 %
61.27 %
61.27 %
61.27 %
61.27 %
61.27 %
61.27 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.39 %
0.39 %
0.00 %
0.39 %
0.39 %
0.00 %
0.39 %
0.39 %
0.39 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.49 %
29.45 %
29.28 %
30.60 %
31.62 %
29.57 %
29.96 %
29.98 %
29.80 %
29.73 %
29.63 %
29.65 %
29.93 %
30.54 %
30.86 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,402.85 1,16,477.70 67.02 10,785.70 11.59 1,656 17.36 54.82
Gland Pharma
1,901.10 30,347.30 43.89 5,835.00 50.97 773 -15.77 67.23
Caplin Point Laboratories
2,537.55 19,456.70 39.43 1,761.00 15.65 461 12.66 63.37
Eris Lifesciences
1,297.35 17,986.80 51.58 2,033.00 19.85 397 -21.26 34.18
Sai Life Sciences
779.90 15,989.20 193.71 1,494.30 20.01 83 - -
Marksans Pharma
297.90 13,526.10 38.90 2,227.80 16.55 315 16.71 44.10
Shilpa Medicare
839.45 8,163.60 142.04 1,159.80 8.65 32 1,018.75 53.87
Jeena Sikho Lifecare
2,360.60 5,468.10 163.78 207.30 40.07 34 - 64.53
Ajanta Pharma
2,873.75 3,532.90 42.44 4,293.30 11.77 816 10.86 46.91
Senores Pharmaceuticals
573.15 2,638.40 83.74 217.30 457.18 33 - -

Corporate Action

Technical Indicators

RSI(14)
Neutral
68.07
ATR(14)
Volatile
13.77
STOCH(9,6)
Neutral
66.80
STOCH RSI(14)
Overbought
91.39
MACD(12,26)
Bullish
4.39
ADX(14)
Strong Trend
26.53
UO(9)
Bearish
52.93
ROC(12)
Uptrend And Accelerating
24.70
WillR(14)
Neutral
-27.80
Bearish
3
Neutral
3
Bullish
3
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Candlestick Screeners
Fundamental Screeners
Intraday Screeners
Technical Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.